Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$421,679
in 7 filings, $422K under 10b5-1 plans

Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-21 Forbion Capital Fund IV Cooperatief U.A. 10% owner Conversion · Series B Preferred Stock −5,336,179 0
2020-09-21 CureDuchenne Ventures, LLC 10% owner Conversion +602,972 602,972
2020-09-21 CureDuchenne Ventures, LLC 10% owner Conversion · Series A Preferred Stock −2,000,000 0
2020-09-21 Klein Lawrence Otto Director Conversion +10,725 10,725
2020-09-21 Klein Lawrence Otto Director Conversion · Series B Preferred Stock −35,574 0
2020-09-21 Stehman-Breen Catherine Director Conversion +10,725 115,713
2020-09-21 Stehman-Breen Catherine Director Conversion · Series B Preferred Stock −35,574 0
2020-09-21 Rhodes Jason P Director Conversion +6,029,726 8,140,130
2020-09-21 Rhodes Jason P Director Conversion +1,608,785 1,608,785
2020-09-21 Rhodes Jason P Director Conversion · Series A Preferred Stock −20,000,000 0
2020-09-21 Rhodes Jason P Director Conversion · Series B Preferred Stock −5,336,179 0
2020-09-21 Kersten Dirk Director Conversion +6,131,079 6,131,079
2020-09-21 Kersten Dirk Director Conversion · Series A Preferred Stock −15,000,000 0
2020-09-21 Kersten Dirk Director Conversion · Series B Preferred Stock −5,336,179 0
2020-09-21 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion +1,608,785 1,608,785
2020-09-21 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion · Series B Preferred Stock −5,336,179 0
2020-09-21 Atlas Venture Fund XI, L.P. 10% owner Conversion +6,029,726 8,140,130
2020-09-21 Atlas Venture Fund XI, L.P. 10% owner Conversion +1,608,785 1,608,785
2020-09-21 Atlas Venture Fund XI, L.P. 10% owner Conversion · Series A Preferred Stock −20,000,000 0
2020-09-21 Atlas Venture Fund XI, L.P. 10% owner Conversion · Series B Preferred Stock −5,336,179 0

Page 39 of 41 · 818 trades